Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.
Metrics to compare | 096530 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship096530PeersSector | |
---|---|---|---|---|
P/E Ratio | 118.3x | 6.4x | −0.5x | |
PEG Ratio | 0.29 | 0.05 | 0.00 | |
Price/Book | 1.3x | 2.2x | 2.6x | |
Price / LTM Sales | 2.9x | 9.3x | 3.3x | |
Upside (Analyst Target) | 58.1% | 39.0% | 42.9% | |
Fair Value Upside | Unlock | 12.1% | 6.2% | Unlock |